AAPG Financials
Ascentage Pharma Group International - Financial statements & key metrics
Stock Price
$26.01
Market Cap
$2.53B
EPS
$-2.08
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$980.65M
Gross Profit
$951.57M
Operating Income
$-369.73M
Net Income
$-405.43M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$2.62B
Total Liabilities
$2.34B
Shareholders Equity
$264.19M
Cash & Equivalents
$1.24B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-111.36M
CapEx
$24.29M
Free Cash Flow
$-135.65M
Profitability Metrics
Gross Margin
90.9%
Operating Margin
-2.4%
Net Margin
-3.0%
ROE
-1.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AAPG revenue?
AAPG's most recent quarterly revenue was $980.65M. Annual revenue can be calculated by summing the four most recent quarters.
Is AAPG profitable?
AAPG reported a loss of $405.43M in the most recent quarter. The net profit margin is -3.0%.
What is AAPG market cap?
AAPG has a market capitalization of $2.53B, making it a mid-cap stock.
Does AAPG have debt?
View AAPG's balance sheet for debt information.
What is AAPG cash flow?
AAPG's most recent quarterly free cash flow was $-135.65M.